Literature DB >> 18834374

Treatment of panic disorder with bupropion in a patient with Parkinson's disease.

S Gebhardt1, H Röttgers, A Bäcker, U Schu, J-C Krieg.   

Abstract

We report on a 57-year-old woman, diagnosed with Parkinson's disease, whose panic disorder showed marked improvement after introduction of bupropion, a norepinephrine-dopamine reuptake inhibitor. Additionally a comorbid major depression disappeared under this treatment. Bupropion may be useful for the treatment of patients with both panic disorder and Parkinson's disease.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18834374     DOI： 10.1111/j.1365-2710.2008.00952.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN： 0269-4727            Impact factor:   2.512


  4 in total

Review 1.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 2.  Clinical uses of Bupropion in patients with Parkinson's disease and comorbid depressive or neuropsychiatric symptoms: a scoping review.

Authors:  Matteo Vismara; Beatrice Benatti; Gregorio Nicolini; Ilaria Cova; Edoardo Monfrini; Alessio Di Fonzo; Vincenza Fetoni; Caterina A Viganò; Alberto Priori; Bernardo Dell'Osso
Journal:  BMC Neurol       Date:  2022-05-05       Impact factor: 2.903

3.  Pathological gambling in a patient on piribedil: A case report.

Authors:  Yingtan Wang; Zhe Lu; Guanglei Xun
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

4.  Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.

Authors:  Christopher C Yang; Mengnan Zhao
Journal:  J Med Internet Res       Date:  2018-10-11       Impact factor: 5.428
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.